Commercialization: Page 120
-
Neil Levine: In Good Company
In Good Company By Kim Ribbink Neil Levine has spent most of his career at one company, Pfizer, not only because of the myriad opportunities he has been given at the world’s largest pharmaceutical company, but, he says, because of the people he works with, the company’s values, And its commitment...
By Kim Ribbink • Jan. 2, 2008 -
Letter from the Editor
Letter From The Editor According to Cutting Edge Information’s study, 88% of surveyed companies’ market-research teams were involved in collecting and analyzing competitive intelligence. Companies across multiple industries are recognizing the overlap between market research and competitive intel...
By Taren Grom • Jan. 2, 2008 -
Applied Competitive Intelligence
Pharma Forum Applied Competitive Intelligence By Denise Myshko A broader approach to the field of competitive intelligence where market research is combined with other data services, as well as the more traditional aspects of the discipline, is providing decision makers with better insight into t...
By Denise Myshko • Jan. 2, 2008 -
E-Media
E-Media New electronic and web-based applications, sites, and technologies Suite of Drug-Development Tools Is Available From Bruker Daltonics Bruker Daltonics has introduced the PharmaTools suite of products, which includes a feature to automatically build up libraries, i.e. for natural compounds...
By PharmaVoice Team • Jan. 2, 2008 -
Cover
On the Cover Featured on the Cover Competitive Intelligence: Driving Better Decision Making Channeling a New Direction with Neil Levine Global Trials: Tapping New Opportunities September 2004 Volume 4 Number 9 www.pharmavo...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaTrax
Pharma Trax Sales, marketing, And R&D Trends affecting the healthcare industry Technology Will Revolutionize Pharma by 2010 Seven key technologies will allow pharmaceutical companies to reduce drug-development costs by 75% and cut lead times by nine years. This is the finding of a recent repo...
By PharmaVoice Team • Jan. 2, 2008 -
Letter from the Editor
Letter From the Editor Relationship building Life-cycle management takes the knowledge, savvy, and experience in all areas of pharmaceutical development, from product formulation and clinical development to navigating the regulatory review process, to building an effective marketing strategy and ...
By Taren Grom • Jan. 2, 2008 -
PharmaCounsel
Pharma Counsel Legal Counsel: Public Perception Minimizing Liability, Maximizing Public Perception Public perception is often more powerful than reality. If a majority believes something is true, whether it is or not is beside the point. Pharmaceutical companies are facing a difficult reality: ho...
By PharmaVoice Team • Jan. 2, 2008 -
For Art's Sake
Creative Review Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single brand...
By PharmaVoice Team • Jan. 2, 2008 -
Raise Your Voice -- Letters
Raise your voice Letters Times have changed In today’s highly competitive environment, experience and training together will be of great help in the development of managers. — Avinash L. Salunke Manager development The April 2004 story, Coaching: Developing a Playbook for Sales Rep Success, was v...
By PharmaVoice Team • Jan. 2, 2008 -
What's New
What’s new New healthcare-related products, services, and companies inChord Launches Stonefly Communications Group New agency will use customer-centric business model. inChord Communications Inc. has launched a new full-service advertising agency: Stonefly Communications Group, which will focus o...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaOutlet
Contributed by Ash Nashed, M.D. Beyond Synergy Why DTC Demands Convergence Dozens of publications — ranging from the Wall Street Journal to Media Life — have printed stories documenting the link in pharmaceutical advertising between television and the Internet. These two alternatives, long consid...
By PharmaVoice Team • Jan. 2, 2008 -
Table of Contents
Contents August 2004 Chris Henshall says all members of the brand team need a strategic understanding of the business. on the cover Life-cycle management: The ultimate client-agency relationship Life-cycle management is best achieved through a team approach that includes all stakeholders. Agencie...
By PharmaVoice Team • Jan. 2, 2008 -
Cover
August 2004 PharmaVOICE The forum for the industry executive Working Toward Common Goals agency-Client relationships a journey of discovery with Frank Baldino Deriving Value from patient registries www.pharmavoice.com Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
Patient Registries: Observations of the Real World
Patient registries Observations of the Real World By Denise Myshko There is no such thing as a standard registry. We have to strike a balance: do we ask a lot of questions or just a few? We also need to consider the work load for the investigators. DR. herve Caspard Through patient registries, ph...
By Denise Myshko • Jan. 2, 2008 -
For Art's Sake
Creative Review Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single brand...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaTrax
Pharma Trax Sales, Marketing, and R&D Trends affecting the healthcare industry The Biodefense Market to Grow Biodefense research is one of the fastest growing markets for suppliers of life-sciences products and instrumentation. When the budget allocated to the Department of Health and Human S...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaCase
Making a Case for Rebranding The Rebranding of a Brander Healthcare advertising agencies, among their many strategic and creative services, excel at branding or rebranding pharmaceutical products, devices, diagnostics, and corporate identities for their clients. Harder to do is to apply those sam...
By PharmaVoice Team • Jan. 2, 2008 -
What's New
What’s New New healthcare-related products, services, and companies PhRMA Adopts Clinical-Trial Principles Voluntary principles describe the relationship of PhRMA companies with others involved in clinical research and establish the rules to protect the safety of research participants. The Pharma...
By PharmaVoice Team • Jan. 2, 2008 -
Trials Around the World
Trials Around the World By Denise Myshko Many pharmaceutical companies and CROs are tapping Eastern Europe, Asia, Latin America, and other areas to meet their clinical-trial needs. While there are challenges associated with conducting research in nontraditional geographic regions – such as nascen...
By PharmaVoice Team • Jan. 2, 2008 -
Beyond Passwords
Beyond Passwords By Denise Myshko Biometrics – technologies that allow people to be identified by fingerprints or other biological markers, such as iris scans – is receiving increased attention by companies in many industries concerned about security, not only for their premises but also for thei...
By PharmaVoice Team • Jan. 2, 2008 -
Talent Pool
Talent Pool Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Christopher Clement Savient Pharmaceuticals Names CEO Savient Pharmaceuticals has named Christopher Clement CEO, in addition to his role as president. Savient, East Brunswick, N.J., is engaged in developing, ...
By PharmaVoice Team • Jan. 2, 2008 -
Improving Advocacy Relations
Improving Advocacy relations By Elisabeth Pena By forming relationships with advocacy organizations, pharmaceutical companies can better serve their target patient populations, which in turn will give them allies in the court of public opinion. P harmaceutical companies are in the middle of a pub...
By PharmaVoice Team • Jan. 2, 2008 -
Life-Cycle Management: The Ultimate Client-Agency Relationship
Life-cycle Management The Ultimate Client-Agency Relationship By Elisabeth Pena With $80 billion of products facing patent expiration by 2008, fewer drugs in the pipeline, greater generic competition, and decreasing revenue and growth rates, the pharmaceutical industry is facing some of its bigge...
By PharmaVoice Team • Jan. 2, 2008